Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatifen Fumarate Capsules in Seasonal Allergic Rhinitis
NCT07711262Phase 3Recruiting
- Sponsor
- Mindong Lijiu Pharmaceutical
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 3 trial of rupatifen fumarate in seasonal allergic rhinitis (SAR), sponsored by Mindong Lijiu Pharmaceutical. Started Aug 2026; status: recruiting.
02
Drugs
rupatifen fumarate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT07711262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07711262.